Nancy G. Brinker: Our Founder, Our Leader, Presidential Medal Of Freedom Recipient

We are pleased to share with the entire Komen Philadelphia Affiliate family an exciting announcement that, once again, demonstrates the leadership of Susan G. Komen for the Cure® in the global battle against breast cancer. Our founder, Ambassador Nancy G. Brinker, recently receive the Presidential Medal of Freedom - our nation's highest civilian honor - in a ceremony at the White House on August 12. She joins a prestigious group of medal honorees that includes Desmond Tutu, Senator Edward Kennedy, and physicist Stephen Hawking.


This honor, coupled with Nancy's appointment as Ambassador for Cancer Control in the World Health Organization, is an extraordinary recognition of Komen for the Cure's impact here in the Komen Philadelphia Affiliate's 13-county service area, and around the world. In just one generation, Nancy's leadership and vision have enabled Komen to invest more than $1.3 billion into research, education and community health programs across the United States and beyond our borders.

 

These investments have brought new treatments, better outcomes and better support for millions of women and men in the United States facing a breast cancer diagnosis.

 

Around the world, almost a decade of Komen's work with governments and health leaders is bearing fruit in the Middle East, Eastern Europe, Latin America and Africa... low- and middle-income areas of the world where the need is very great and resources for women are very scarce.

 

Nancy Brinker will be undertaking significant cancer challenges in her role with the World Health Organization. Fortunately, twenty-seven years doing the tough work, at the forefront of the breast cancer movement, has prepared her, as well as Komen, for the challenges ahead.

 

We hope you will continue to join the Komen Philadelphia Affiliate in our local - and global - battle against breast cancer... and, as always, thank you for you dedication to the Komen vision of a world without breast cancer.